Genome Technology Access Center (GTAC)

LEADERSHIP: Shawn Shafer, PhD

Positioned within the Washington University (WU) McDonnell Genome Institute (MGI), the Genome Technology Access Center (GTAC) provides access to all of its genomics technologies and services to Siteman Cancer Center researchers at WU and beyond. In addition to research services, GTAC provides access to numerous clinical platforms. Services include next-generation sequencing, spatial transcriptomics, microarray analyses, high-throughput proteomics, high-throughput polymerase chain reaction and other specialized services on a fee-for-service basis. Clinical sequencing and microarrays are done in College of American Pathologists (CAP)/Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories. Assistance is available at all stages of a project, including experimental design, sample preparation, quality control, samples/protocols processing, data management, analysis, and interpretive analytics. As a large and collaborative shared resource, GTAC aims to provide oncology researchers with economic, cutting-edge, and innovative tools and technologies.

LOCATION: Cortex Building, Room 205, 4320 Forest Park Ave

PRICING: Please contact the core for current pricing of services offered.

TO ACCESS: Call 314-286-1276 or e-mail [email protected]

NIH PUBLIC ACCESS POLICY: As of April 7, 2008, the NIH requires investigators with a publication using Siteman (or other NIH-funded) shared resources to submit (or have submitted for them) their final, peer reviewed manuscripts to PubMed Central(PMC) upon acceptance of publication, to be made publicly available within 12 months of publication. Many journals automatically submit these for authors, but Washington University also has assistance available through the Becker Medical Library. Please see this resource for more information.

PUBLICATION ACKNOWLEDGEMENT: If research supported by the Genome Technology Access Center results in publication, please acknowledge this support by including the following in your publication(s):

We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO. and the Institute of Clinical and Translational Sciences (ICTS) at Washington University in St. Louis, for the use of the Genome Technology Access Center, which provided __________ service. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA091842 and the ICTS is funded by the National Institutes of Health’s NCATS Clinical and Translational Science Award (CTSA) program grant #UL1 TR002345.